Back to today’s briefing

Story perspectives

Medsafe Approves Two Psychiatrists to Prescribe MDMA for PTSD

9/4/2026

30 4 Full Breakdown

Summary

Story summary

Medsafe approved two psychiatrists to prescribe pharmaceutical-grade MDMA for PTSD treatment.
Associate Health Minister David Seymour announced the approval, saying it aligns New Zealand with Australia.
Patients must be 18 or older, undergo clinical assessment, and receive MDMA only in supervised sessions.
Only the two approved psychiatrists may prescribe MDMA; other clinicians need separate Medsafe approval.

1 of 1

Story summary

Medsafe approved two psychiatrists to prescribe pharmaceutical-grade MDMA for PTSD treatment.
Associate Health Minister David Seymour announced the approval, saying it aligns New Zealand with Australia.
Patients must be 18 or older, undergo clinical assessment, and receive MDMA only in supervised sessions.
Only the two approved psychiatrists may prescribe MDMA; other clinicians need separate Medsafe approval.